SIRFLOX_3 | R Documentation |
Kaplan-Meier digitized data from SIRFLOX, figure 3 (PMID 26903575). A reported sample size of 530 for a primary endpoint of PFS in colorectal cancer.
SIRFLOX_3
A data frame of 530 observations and 3 variables:
time | event time (in months) | |
event | PFS event indicator (0 : no event, 1 : event) |
|
arm | treatment arms (mfolfox6, mfolfox6_rt) | |
van Hazel GA, Heinemann V, Sharma NK, et al. SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patients With Metastatic Colorectal Cancer. J Clin Oncol 2016; 34: 1723–31.
summary(SIRFLOX_3)
kmplot(SIRFLOX_3)
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.